(UPDATED SEE BOTTOM OF POST) — The New World Order agenda regarding Gene Editing has begun, the first human trials are set to take place in China using new technology called CRISPR.
Chinese researchers received ethical approval for gene editing using the CRISPR-Cas9 technique on humans. The pivotal moment in history has come. Technology and science will now fully attempt to recreate man through genome editing.
A team led by Lu You, an oncologist at Sichuan University’s West China Hospital in Chengdu, plans to start testing such cells in people with lung cancer next month. The clinical trial received ethical approval from the hospital’s review board on 6 July. Chinese scientists are on the verge of being first in the world to inject people with cells modified using the CRISPR–Cas9 gene editing technique.
“It’s an exciting step forward,” says Carl June, a clinical researcher in immunotherapy at the University of Pennsylvania in Philadelphia. All in the name of medicine, science, and technology; researchers plan to alter life systematically.
China and the USA will house almost simultaneous trials; it is a race to the finish to see who can first change genes and fight diseases. Both China and the USA will use the method of CRISPR-CAS9 which involves using Chimeras as Freedom Fighter Times previously discussed. China will have the first go however because the USA is still awaiting approval from the FDA.
Genome-editing to fight diseases is not the endgame, nor is it a new idea, rather scientists have held dreams of the opportunity to edit mankind and remove the work of God in DNA structures. DNA is the building block of life and allowing mankind to manipulate such structure will have dire consequences. It is crucial to note the investigation that took place into who is involved with this research.
During the RAC meeting, one of the committee’s greatest concerns was a potential conflict of interest. Among other financial involvements, June has ties to the pharmaceutical company Novartis, holds patents on T-cell technologies, and could stand to benefit from the success of this trial. June declined to give details on the exact nature of his conflicts of interest, but says that his university is taking steps to manage it, such as preventing him from being involved in selecting patients.
Several RAC reviewers suggested that the University of Pennsylvania not be allowed to recruit patients at all and to leave it to other institutions: this language did not make it into their final approval.
Big Pharma is directly involved with the push to begin editing genomes to “cure” cancer. When in reality the people who could have cured cancer are were killed off.
Genetically Engineering mankind is also in the interests of Bill and Melinda Gates, who funded the genetically modified mosquitoes which are causing microcephaly throughout the world.
Since the dawn of genetically engineered crops, mankind has suffered greatly because of the unknown effects on the microbiome, as well as the rise of superbugs. Now, the very building blocks of DNA will be altered in a way in which mankind cannot return.
Due to the potential high risk of CRISPR, the researchers will proceed on their trial slowly, increasing the dosage gradually with just one patient, who will monitored closely for side-effects. The researchers will also keep a watchful eye on blood markers that could indicate if the treatment is working.
According to a report from CBC, CRISPR has the potential to make unpredicted genetic changes in unwanted places. It could trigger a fatal immune response known as cytokine storm that can lead to death. There is also the possibility that the edited cell to attack cancer could end up destroying normal, healthy cells.
The CRISPR technology uses chimeras to alter genes or in other words RNA from other species. There are two segments involved in their new system; CAS9 and trcrRNA-crRNA chimera. The system will cut the cells genome at the desired location, allowing existing genes to be removed and/or new ones added.
Manipulating the CRISPR and CAS system is the beginning of designer babies because that is the not-so-futuristic goal of modern medicine, which would remove the hand of God from creation and allow man to start a new species. Rockefeller University created the first artificial human embryo in a quest to create an artificial womb through the process called ectogenesis.
In a move that will systematically alter the genome of life on Earth, science plans to restructure DNA and RNA in what they claim to be the attempt to “perfect” the human race. Meanwhile, the real purpose is a paycheck, and for the ones dishing the paycheck the plan is to recreate the trans-species of old known as chimeras or the Nephilim.
Scientists create ‘artificial womb’ that could save premature babies’ lives – The Independent
(Katie Forster) — Extremely premature babies could be kept alive in future using an “artificial womb” that scientists plan to test in humans after a successful study involving unborn lambs.
A plastic bag filled with artificial amniotic fluid – the nutrient-rich liquid that sustains a foetus in the womb – allowed foetal lambs to develop at an age equivalent to 23 weeks in humans.
Human infants born at 23 weeks have just a 15 per cent chance of survival, according to pregnancy research charity Tommy’s. This rises to 55 per cent at 24 weeks, while babies born at 25 weeks have an 80 per cent chance of survival.
Premature babies are often placed in incubators to help keep them warm, but the new invention closely replicates conditions in a real womb, scientists at the Center for Fetal Research at the Children’s Hospital of Philadelphia have said.
“This system is potentially far superior to what hospitals can currently do for a 23-week-old baby born at the cusp of viability,” said Dr Alan Flake, the Centre’s director. – Read More
Chinese researchers have become the first to inject a person with genes that have been modified using the CRISPR–Cas9 technique.
Updated on November 15th, 2016 NATURE) — A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique.
On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, also in Chengdu.
Earlier clinical trials using cells edited with a different technique have excited clinicians. The introduction of CRISPR, which is simpler and more efficient than other techniques, will probably accelerate the race to get gene-edited cells into the clinic across the world, says Carl June, who specializes in immunotherapy at the University of Pennsylvania in Philadelphia and led one of the earlier studies.
“I think this is going to trigger ‘Sputnik 2.0’, a biomedical duel on progress between China and the United States, which is important since competition usually improves the end product,” he says.
June is the scientific adviser for a planned US trial that will use CRISPR to target three genes in participants’ cells, with the goal of treating various cancers. He expects the trial to start in early 2017. And in March 2017, a group at Peking University in Beijing hopes to start three clinical trials using CRISPR against bladder, prostate and renal-cell cancers. Those trials do not yet have approval or funding. – Read More
(End of Updates) Last Updated on April 25th, 2017 at 12:00 AM EST
Sound off in the comments below!
John Raphael . “First Ever CRISPR Gene-Editing Trial on Human to Begin in China.” Nature World News. . (2016): . . http://www.natureworldnews.com/articles/25743/20160725/first-crispr-gene-editing-trial-human-begin-china.htm
David Cyranoski. “Chinese scientists to pioneer first human CRISPR trial.” Nature. . (2016): . . http://www.nature.com/news/chinese-scientists-to-pioneer-first-human-crispr-trial-1.20302?WT.mc_id=TWT_NatureNews
David Cyranoski. “CRISPR gene-editing tested in a person for the first time.” Nature. . (2016): . . http://go.nature.com/2fIYWOj